Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Receptor-mediated DNA-targeted photoimmunotherapy.
Karagiannis TC, Lobachevsky PN, Leung BK, White JM, Martin RF. Karagiannis TC, et al. Among authors: martin rf. Cancer Res. 2006 Nov 1;66(21):10548-52. doi: 10.1158/0008-5472.CAN-06-1853. Cancer Res. 2006. PMID: 17079478
Radiation sensitization by an iodine-labelled DNA ligand.
Martin RF, Murray V, D'Cunha G, Pardee M, Kampouris E, Haigh A, Kelly DP, Hodgson GS. Martin RF, et al. Int J Radiat Biol. 1990 May;57(5):939-46. doi: 10.1080/09553009014551061. Int J Radiat Biol. 1990. PMID: 1692580
Radioprotection by DNA ligands.
Martin RF, Broadhurst S, D'Abrew S, Budd R, Sephton R, Reum M, Kelly DP. Martin RF, et al. Br J Cancer Suppl. 1996 Jul;27:S99-101. Br J Cancer Suppl. 1996. PMID: 8763857 Free PMC article.
Modelling of Auger-induced DNA damage by incorporated 125I.
Nikjoo H, Martin RF, Charlton DE, Terrissol M, Kandaiya S, Lobachevsky P. Nikjoo H, et al. Among authors: martin rf. Acta Oncol. 1996;35(7):849-56. doi: 10.3109/02841869609104036. Acta Oncol. 1996. PMID: 9004762
Cytotoxicity of an 125I-labelled DNA ligand.
Karagiannis TC, Lobachevsky PN, Martin RF. Karagiannis TC, et al. Among authors: martin rf. Acta Oncol. 2000;39(6):681-5. doi: 10.1080/028418600750063721. Acta Oncol. 2000. PMID: 11130004
In vitro studies with methylproamine: a potent new radioprotector.
Martin RF, Broadhurst S, Reum ME, Squire CJ, Clark GR, Lobachevsky PN, White JM, Clark C, Sy D, Spotheim-Maurizot M, Kelly DP. Martin RF, et al. Cancer Res. 2004 Feb 1;64(3):1067-70. doi: 10.1158/0008-5472.can-03-2423. Cancer Res. 2004. PMID: 14871839
270 results